Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Quality of life after lower wisdom tooth extraction with preemptive nimesulide vs etoricoxib plus dexamethasone
RBR-9gm2fgfTerminated
- Sponsor
- Universidade Federal de Pernambuco
- Start
- Mar 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of nimesulide, etoricoxib and dexamethasone in Impacted lower third molar (2 arms), sponsored by Universidade Federal de Pernambuco. Primary endpoint: Quality of life after lower wisdom tooth extraction. Started Mar 2022; status: terminated.
02
Drugs
nimesulideetoricoxibdexamethasone
03
Conditions
Impacted lower third molar
Beyond the preview
Go deeper on RBR-9gm2fgf.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-9gm2fgf.